Author:
Akram Muhammad,Adetunji Charles Oluwaseun,Egbuna Chukwuebuka,Jabeen Shaista,Olaniyan Olugbemi Tope,Ezeofor Nebechi Jane,Anani Osikemekha Anthony,Laila Umme,Găman Mihnea‐Alexandru,Patrick‐Iwuanyanwu Kingsley C.,Ifemeje Jonathan Chinenye,Chikwendu Chukwudi Jude,Olisah Michael C.,Rudrapal Mithun
Reference70 articles.
1. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
2. In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
3. Parks W.andLloyd L.(2004).Planning social mobilization and communication for dengue fever prevention and control: a step‐by‐step guide.https://www.who.int/denguecontrol/resources/9241591072/en(accessed 21 September 2020).
4. World Health Organization(2017).Weekly bulletin on outbreaks and other emergencies: week 44: 28 October–3 November.Weekly Bulletin on Outbreaks and Other Emergencies:1–15.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medical Imaging Systems Using Blockchain;Blockchain Technology in Healthcare - Concepts, Methodologies, and Applications;2023-11-26
2. Blockchain Distributed Ledger Technologies for Biomedical and Healthcare Applications;Blockchain Technology in Healthcare - Concepts, Methodologies, and Applications;2023-11-26
3. Blockchain and Clinical Trials for Health Informatics;Blockchain Technology in Healthcare - Concepts, Methodologies, and Applications;2023-11-26
4. Advancing Health Research Data Analysis with Blockchain Technology;Blockchain Technology in Healthcare - Concepts, Methodologies, and Applications;2023-11-26
5. Dengue havoc: overview and eco-friendly strategies to forestall the current epidemic;Environmental Science and Pollution Research;2023-11-22